The increased risk of DKA in the SGLT2i group, and the associated hospitalisation, was not great enough to offset the increased rate of hospitalisation of any cause in the GLP-1 RA group
Thomsen C, Storm H, Holst JJ, Hermansen K
They may recommend: Liver function tests based on clinical judgement and your overall risk profile Strategies to minimise gastrointestinal side effects Referral to diabetes specialist nurses for education on hypoglycaemia prevention Signposting to alcohol support services if appropriate When to contact your GP urgently : Seek medical advice promptly if you experience severe abdominal pain (stop your GLP-1 medication if pancreatitis is suspected), persistent vomiting preventing medication or fluid intake, signs of dehydration, or symptoms of hypoglycaemia that don't resolve with usual measures
A subcutaneous injection is given into the fatty tissue just under the skin
Der Bedarf an L-Carnitin kann normalerweise ber die Nahrung gedeckt werden
Completely different story